SCNI · Scinai Immunotherapeutics Ltd. · Documents
Market Cap
$921,954
Shares
1.35M
Volume · Oct 21
124.74K
Avg daily vol (42 sessions)
3.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Scinai Immunotherapeutics Ltd. reported approximately $5.1 million in committed service fees, Committed Customer Orders of approximately $8.1 million, and approximately $5.3 million in financing proceeds, supporting an operating runway to late 2027 that may extend into the third quarter of 2028. | 2026-10-20 | — | |
| 6-K | Scinai Immunotherapeutics Ltd. closed a private placement and warrant inducement generating approximately $4.0 million in gross proceeds, which it plans to use for customer programs, additional CDMO contracts and selective immunotherapy pipeline investment. | 2026-10-16 | — | |
| 6-K | Scinai Immunotherapeutics Ltd. entered a private placement and warrant inducement generating approximately $4.0 million gross proceeds, with closing expected on or about October 15, 2026, to support CDMO expansion and its immunotherapy pipeline. | 2026-10-15 | — | |
| 6-K | Scinai Biopharma Services Ltd. entered a definitive development and clinical manufacturing agreement with a U.S.-based, Nasdaq-listed biopharmaceutical company, including approximately $5.1 million in committed base service fees. Committed Customer Orders reached approximately $7.6 million. | 2026-10-13 | — | |
| F-1 | — | 2026-09-24 | — | |
| 6-K | — | 2026-09-21 | — | |
| 6-K | — | 2026-09-08 | — | |
| 6-K | — | 2026-08-26 | 2026-06-30 | |
| 6-K | — | 2026-08-19 | — | |
| 6-K | — | 2026-06-17 | — | |
| 6-K | — | 2026-06-15 | — | |
| 6-K | — | 2026-06-08 | — | |
| 6-K | — | 2026-05-12 | — | |
| 6-K | — | 2026-05-08 | 2025-12-31 | |
| F-3 | — | 2026-05-08 | — | |
| 6-K | — | 2026-04-27 | — | |
| 20-F | — | 2026-04-01 | 2025-12-31 | |
| 6-K | — | 2026-03-23 | — | |
| 6-K | — | 2026-03-19 | — | |
| 6-K | — | 2026-02-25 | — | |
| 6-K | — | 2026-02-17 | — | |
| 6-K | — | 2025-12-23 | — | |
| 6-K | — | 2025-12-02 | — | |
| 6-K | — | 2025-11-13 | — | |
| 6-K | — | 2025-11-13 | — | |
| 6-K | — | 2025-10-06 | — | |
| 6-K | — | 2025-09-22 | — | |
| F-1 | — | 2025-09-22 | — | |
| 6-K | — | 2025-09-11 | — | |
| 6-K | — | 2025-09-02 | 2025-06-30 | |
| 6-K | — | 2025-06-12 | — | |
| 6-K | — | 2025-06-05 | — | |
| 6-K | — | 2025-06-02 | — | |
| 20-F | — | 2025-05-07 | 2024-12-31 | |
| NT 20-F | — | 2025-04-29 | 2024-12-31 | |
| 6-K | — | 2025-03-27 | — | |
| 6-K | — | 2025-03-24 | — | |
| F-1/A | — | 2025-03-11 | — | |
| 6-K | — | 2025-03-05 | — | |
| 6-K | — | 2025-03-04 | — | |
| F-1 | — | 2025-03-04 | — | |
| 6-K | — | 2024-11-25 | — | |
| 6-K | — | 2024-11-22 | — | |
| 6-K | — | 2024-10-15 | — | |
| 6-K | — | 2024-09-26 | — | |
| 6-K | — | 2024-09-09 | 2024-06-30 | |
| 6-K | — | 2024-08-29 | — | |
| 6-K | — | 2024-08-21 | — | |
| 6-K | — | 2024-08-20 | — | |
| 6-K | — | 2024-08-15 | — |
Showing 1–50 of 198 filings